SITC Cancer Immunotherapy CONNECT

2021 SITC Logo Crop

SITC 2021: Join us in person or virtually  
Join SITC in Washington, D.C., or virtually, Nov. 10-14, 2021, to take part in the leading destination for scientific exchange, education and networking in the cancer immunotherapy field. Click here for more information about attending SITC 2021.

2021 SITC Logo Crop

Submit your Cutting-Edge Research

The deadline to submit research for a regular abstract, Young Investigator Award abstract and/or late-breaking abstract application is 5 p.m. PDT on July 29, 2021.

cig-big.png

SITC Clinical Practice Guideline Webinar – Multiple Myeloma
A free, hour-long webinar on cancer immunotherapy for multiple myeloma is coming up soon. Advance your understanding with practical management pearls and case-based learning led by expert panel authors from SITC’s clinical practice guideline on June 16 at 5 p.m. ET.  

Learn More and Register Today

sitc_log_color.png

SITC Technology Awards

SITC is pleased to announce two award opportunities that will assist early career investigators in advancing their cancer immunotherapy research by leveraging spatial technology platforms. Applications are due May 13 by 11:59 p.m. EDT.

LEARN MORE

sitc_log_color.png

Targets for Cancer Immunotherapy: A Deep Dive

A series of eight two-hour online seminars will feature experts in a given subject area to provide an overview of the current scientific knowledge about an area of immunotherapy. An interactive Q&A session will follow the topic overview, providing attendees the opportunity to ask in-depth questions of the faculty as well as offering a forum for networking and initiation of collaborations with others working in a similar field. 

LEARN MORE AND REGISTER


Surfaceome2

SITC's Surfaceome Workshop

Attend the SITC Interrogating the Tumor-Specific Surfaceome for Immune Targeting Workshop, Sept. 29–30, 2021, in San Diego. This SITC workshop will focus on the tumor cell surfaceome and the many opportunities that accompany it for the development of future immunotherapies and the maximization of existing techniques. Submit your research by 5 p.m. PDT on July 22.

SUBMIT AN ABSTRACT and REGISTER


Surfaceome2

SITC's Bispecific T cell Engagers Workshop

Attend SITC's Bispecific T cell Engagers Workshop, Sept. 30–Oct. 1, 2021, in San Diego. This SITC workshop will focus on T cell engager biology and therapeutic strategies including target selection, therapeutic engineering and design features, cytotoxicity vs cytokine release, the impact of the tumor microenvironment, and advances in conditionally-active binding.

LEARN MORE AND REGISTER

JITCREVIEW.png

JITC Special Series: COVID-19 and Cancer Immunotherapy

Comprised of several authoritative reviews of COVID-19 and Cancer Immunotherapy, this series, edited by Paolo Antonio Ascierto, MD and Jason D. Goldman, MD, MPH, will explore basic insights into the immunology of the novel coronavirus, repurposing of immune-based therapies including the effects of immune-oncology agents, and the affected cancer populations.


Surfaceome2

SITC's Cytokines in Cancer Immunotherapy Workshop

Attend SITC's Cytokines in Cancer Immunotherapy Workshop, Oct. 11–12, 2021, in New York. This SITC workshop will focus on providing a deeper understanding of cytokines in immune cell proliferation, differentiation, and function, as they pertain to tumor immunobiology and cancer immunotherapy approaches. Submit your research by 5 p.m. EDT on July 22.

submit an abstract and REGISTER

Now Available: SITC Clinical Practice Guideline on Immunotherapy for the Treatment of Lymphoma

20-WhyMem-v152.jpg

Why I'm a SITC Member

Join Alan Hutson, PhD, and the thousands of other cancer immunotherapy professionals who proudly call themselves SITC members.

Become a SITC Member


New Online Patient Course Available: Understanding Cancer Immunotherapy 
Access SITC’s dedicated resource for patients and caregivers to learn about cancer immunotherapy

aci17-Online-clr.png

Immunotherapy for the Treatment of Breast and Gynecologic Cancers 

A free, interactive course, part of the Advances in Cancer Immunotherapy™ online education series.

Register Now



Consistent with the Safer at Home Order issued by the Department of Health Services of the State of Wisconsin, all SITC Executive Office staff will be working remotely beginning March 25 and are best reached through email. General inquiries can be sent to info@sitcancer.org. Thank you for understanding.

Patient

Explore resources and educational opportunities for cancer patients and those who advocate for them.

Explore

 

 

 

 

Clinician

Track the latest advancements and educational opportunities in tumor immunology and cancer immunotherapy.

Explore

 

 

 

 

Researcher

Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.

Explore

 

 

 

 

Latest Discussions

  • Presentations from the 2019-2020 Advances in Cancer Immunotherapy™ Series – Tucson, AZ virtually held on October 31, 2020 are now available in the SITC Resource Library. Click here to access ACI – Tucson presentations. You can also reach these materials ...

  • Presentations from the 2019-2020 Advances in Cancer Immunotherapy™ Series – Seattle, WA virtually held on October 31, 2020 are now available in the SITC Resource Library. Click here to access ACI – Seattle presentations. You can also reach these materials ...

  • Presentations from the 2020-2021 Advances in Cancer Immunotherapy™ Series – New Haven, CT virtually held on October 28, 2020 are now available in the SITC Resource Library. Click here to access ACI – New Haven presentations. You can also reach these ...

Follow the SITC Twitter Feed.

 

Connect with colleagues at these Upcoming Events.

 


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.

 

Learn More

 

The Journal & The Blog

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More

 

Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

 

Learn More